查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1663500

芹菜素市場，按來源、形式、應用、國家和地區分類 - 2025 年至 2032 年全球產業分析、市場規模、市場佔有率和預測

Apigenin Market, By Source, By Form, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年芹菜素市場規模價值為 37.2032 億美元，2025 年至 2032 年期間複合年成長率為 4.50%。

芹菜素市場-市場動態

製藥和營養品產業對天然抗氧化劑和抗癌化合物的需求不斷增加

隨著消費者健康意識的不斷增強，他們越來越傾向於選擇植物性和天然化合物，而非合成化合物，因為它們的副作用較小，而且對健康有益。芹菜素以其強大的抗氧化特性而聞名，有助於對抗氧化壓力，這是心血管疾病、神經退化性疾病和衰老相關問題等慢性病的關鍵因素。此外，其誘導細胞凋亡和抑制腫瘤細胞增殖等抗癌作用使其在癌症預防和治療研究中備受追捧。在營養保健食品中，芹菜素擴大用於針對免疫支持、抗發炎作用和整體健康的膳食補充劑中，反映了對預防性醫療保健解決方案日益成長的需求。根據印度傳統醫學部的報告，由於政府支持的推廣傳統醫藥和草藥的舉措，包括天然抗氧化劑在內的全球植物性健康產品市場正在大幅成長。這種轉變符合更廣泛的健康趨勢，即青睞天然化合物而非合成成分，凸顯了芹菜素在塑造藥品和營養保健品未來方面的關鍵作用。永續採購和技術進步將進一步增強其市場潛力。

芹菜素市場 - 關鍵見解

  • 根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 4.50%
  • 根據來源細分，預計天然將在 2024 年佔據最大市場佔有率
  • 根據應用細分，食品和飲料是 2024 年的領先細分市場
  • 從地區來看，北美是 2024 年最大的收入來源

芹菜素市場-細分分析：

全球芹菜素市場根據來源、形式、應用和地區進行細分。

根據來源，市場分為兩類：天然和合成。由於消費者越來越青睞植物性、環保、副作用小、健康益處明顯的產品，天然產品在市場上佔據了主導地位。此外，對有機成分的監管支持進一步推動了對芹菜素等天然化合物的需求。

根據應用，市場分為四類：藥品、食品和飲料、化妝品和個人護理以及膳食補充劑。食品和飲料因其廣泛用作天然抗氧化劑和防腐劑、延長產品保存期限和營養價值而佔據市場主導地位。消費者對富含有益健康的生物活性化合物的功能性食品和飲料的需求不斷成長，進一步推動了其主導地位。

芹菜素市場-地理洞察

在北美，特別是美國，消費者對藥品、營養品和功能性食品中的天然和植物成分的偏好日益成長，使其成為芹菜素的主要市場之一。人們對抗氧化劑和抗癌化合物的健康益處的認知不斷提高，這支持了這一需求。此外，強而有力的監管框架和研究的進步也促進了該地區市場的成長。在歐洲，由於食品、飲料和個人護理領域中有機和天然產品的流行趨勢日益成長，市場正在不斷擴大。歐盟對食品和化妝品中合成化學物質的嚴格規定增加了芹菜素等植物成分的採用，進一步推動了市場成長。亞太地區，尤其是印度和中國等國家，芹菜素市場正在快速成長，這得益於人們日益轉向傳統草藥和保健品和食品中的天然產品。政府倡導在醫療保健中使用草藥和天然成分的措施也促進了該地區市場的擴張。

芹菜素市場－競爭格局：

芹菜素市場競爭激烈，許多參與者致力於滿足市場對天然抗氧化劑和健康促進化合物日益成長的需求。主要市場參與者採用產品創新、合作夥伴關係和協作等各種策略來鞏固其市場地位。各公司正在投資研發，以提高芹菜素的生物利用度和有效性，推動其在藥品、營養品和化妝品中的應用。此外，向植物和有機成分的轉變導致供應商之間的競爭加劇，以從天然和永續來源獲取高品質的芹菜素。就市場佔有率而言，製藥和營養保健品產業競爭激烈，各企業爭相獲得監管部門批准，並開發出吸引注重健康的消費者的配方。食品和飲料行業也面臨競爭，製造商在功能性食品和飲料中加入芹菜素，以滿足對富含抗氧化劑的產品日益成長的需求。此外，化妝品行業擴大利用芹菜素的抗衰老和舒緩皮膚的特性，加劇了美容和個人護理市場的競爭。市場的全球化性質鼓勵參與者擴大國際影響力，探索亞太地區和拉丁美洲等新的區域市場，這些地區的消費者對自然健康解決方案的需求正在迅速成長。

最新動態：

  • 2024 年 5 月，Tally Health 推出了恢復睡眠和長壽配方，這是針對改善睡眠和整體延長壽命的成分混合物。配方結合了多種植物藥和營養保健品，旨在促進放鬆並減少與年齡相關的健康問題。
  • 2024 年 4 月，4Life 推出了 Transfer Factor AgePro，這是一款將芹菜素與其他強效化合物結合的新產品，旨在增強免疫支持並促進長壽。該產品秉承 4Life 對科學支援的配方和專有成分（包括獨家植物萃取物）的承諾，旨在促進健康和保健。

目錄

第 1 章：芹菜素市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 芹菜素市場片段（依來源）
    • 芹菜素市場片段（依形式）
    • 芹菜素市場片段（依應用）
    • 芹菜素市場（按國家）摘要
    • 芹菜素市場片段（按地區）
  • 競爭洞察

第 3 章：芹菜素主要市場趨勢

  • 芹菜素市場促進因素
    • 市場促進因素的影響分析
  • 芹菜素市場限制
    • 市場限制的影響分析
  • 芹菜素的市場機會
  • 芹菜素市場未來趨勢

第 4 章：芹菜素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：芹菜素市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：芹菜素市場格局

  • 芹菜素市佔率分析，2024 年
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：芹菜素市場 - 按來源

  • 概述
    • 按來源分類的細分市場佔有率分析
    • 自然的
    • 合成的

第 8 章：芹菜素市場 - 按形式

  • 概述
    • 按形式細分的佔有率分析
    • 粉末
    • 液體

第 9 章：芹菜素市場 - 依應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 藥品
    • 食品和飲料
    • 化妝品和個人護理
    • 膳食補充劑
    • 其他

第 10 章：芹菜素市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美芹菜素主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模與預測，依來源分類
    • 北美市場規模及預測（按形式）
    • 北美市場規模與預測，按應用分類
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲芹菜素主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模與預測，按來源
    • 歐洲市場規模及預測（按形式）
    • 歐洲市場規模和預測，按應用
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區芹菜素主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依來源分類）
    • 亞太地區市場規模及預測（依形式）
    • 亞太地區市場規模及預測（按應用分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲芹菜素主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按來源分類）
    • 拉丁美洲市場規模及預測（按形式）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲的芹菜素主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模和預測，按來源
    • MEA 市場規模和預測（按形式）
    • MEA 市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-芹菜素產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Monteloeder SL
    • Sigma-Aldrich Corporation
    • Aksuvital GIda Sanayi ve Ticaret AS
    • Bo International Pvt. Ltd.
    • Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • Shaanxi QingLan Bio-Technology Co., Ltd.
    • Xi'an Incedit Bio-Tech Co., Ltd.
    • Xi'an Sost Biotech Co., Ltd.
    • Shaanxi Pioneer Biotech Co., Ltd.
    • Xi'an Lyphar Biotech Co., Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4688

REPORT HIGHLIGHT

Apigenin Market size was valued at US$ 3,720.32 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Apigenin is a bioactive flavonoid widely found in fruits, vegetables, and herbs, particularly in parsley, celery, and chamomile. It is renowned for its antioxidant, anti-inflammatory, and anti-cancer properties. Structurally belonging to the flavone class, apigenin plays a crucial role in health and wellness industries due to its diverse therapeutic benefits and minimal side effects compared to synthetic drugs. The growing need for apigenin is driven by its significant health benefits. As a potent antioxidant, it neutralizes free radicals, reducing oxidative stress, a key factor in aging and chronic diseases. Its anti-inflammatory effects make it valuable for managing arthritis and cardiovascular disorders. Apigenin is also gaining attention in oncology, where it has demonstrated the ability to induce apoptosis and inhibit tumor growth in cancers such as breast, prostate, and colon. Furthermore, its neuroprotective properties support brain health by promoting neuron formation and reducing the risk of neurodegenerative diseases like Alzheimer's. In the cosmetics industry, apigenin is used for its skin-soothing and anti-aging properties, enhancing product formulations aimed at skin rejuvenation. Additionally, its incorporation into dietary supplements addresses consumer demand for natural health-enhancing ingredients, making it a critical compound in various sectors, from pharmaceuticals to nutraceuticals.

Apigenin Market- Market Dynamics

Increasing demand for natural antioxidants and anti-cancer compounds across pharmaceuticals and nutraceutical industries

Increasing health awareness among consumers has led to a rising preference for plant-based and naturally derived compounds over synthetic alternatives, given their reduced side effects and holistic health benefits. Apigenin, known for its potent antioxidant properties, helps combat oxidative stress, a key factor in chronic conditions such as cardiovascular disease, neurodegenerative disorders, and aging-related issues. Furthermore, its anti-cancer effects-such as inducing apoptosis and inhibiting tumor cell proliferation-make it highly sought after in cancer prevention and treatment research. In nutraceuticals, apigenin is increasingly used in dietary supplements targeting immune support, anti-inflammatory effects, and general wellness, reflecting the growing demand for preventive healthcare solutions. According to a report from the Indian Ministry of AYUSH, the global market for plant-based health products, including natural antioxidants, is experiencing substantial growth due to government-backed initiatives promoting traditional and herbal medicines. This shift aligns with broader health trends favoring natural compounds over synthetic ingredients, highlighting the critical role of apigenin in shaping the future of pharmaceuticals and nutraceuticals. Sustainable sourcing and technological advancements will further enhance its market potential.

Apigenin Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)
  • Based on Source segmentation, Natural was predicted to show maximum market share in the year 2024
  • Based on Application segmentation, Food & Beverages was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Apigenin Market- Segmentation Analysis:

The Global Apigenin Market is segmented on the basis of Source, Form, Application, and Region.

The market is divided into two categories based on Source: Natural and Synthetic. Natural dominates the market due to increasing consumer preference for plant-based, eco-friendly products with minimal side effects and proven health benefits. Additionally, regulatory support for organic ingredients further drives demand for naturally sourced compounds like apigenin.

The market is divided into four categories based on Application: Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Dietary Supplements. Food & Beverages dominates the market due to its widespread use as a natural antioxidant and preservative, enhancing product shelf life and nutritional value. Growing consumer demand for functional foods and beverages enriched with health-promoting bioactive compounds further drives its dominance.

Apigenin Market- Geographical Insights

In North America, particularly the United States, there is a growing consumer preference for natural and plant-based ingredients in pharmaceuticals, nutraceuticals, and functional foods, making it one of the leading markets for apigenin. This demand is supported by increasing awareness of the health benefits of antioxidants and anti-cancer compounds. Additionally, the robust regulatory framework and advancements in research contribute to the market's growth in this region. In Europe, the market is expanding due to the rising trend of organic and natural products in food, beverages, and personal care. The European Union's stringent regulations on synthetic chemicals in food and cosmetics have increased the adoption of plant-derived ingredients like apigenin, further fueling market growth. The Asia-Pacific region, especially countries like India and China, is witnessing rapid growth in the apigenin market, driven by a growing shift toward traditional herbal remedies and natural products in health supplements and food. Government initiatives promoting the use of herbal and natural ingredients in healthcare also contribute to the market's expansion in this region.

Apigenin Market- Competitive Landscape:

The Apigenin market is characterized by a competitive landscape with numerous players focused on capitalizing on the increasing demand for natural antioxidants and health-promoting compounds. Key market players adopt various strategies such as product innovation, partnerships, and collaborations to strengthen their market position. Companies are investing in research and development to enhance the bioavailability and effectiveness of apigenin, driving its application across pharmaceuticals, nutraceuticals, and cosmetics. Additionally, the shift towards plant-based and organic ingredients has led to heightened competition among suppliers to source high-quality apigenin from natural and sustainable sources. In terms of market share, the pharmaceutical and nutraceutical sectors are highly competitive, with businesses vying to secure regulatory approvals and develop formulations that appeal to health-conscious consumers. The food and beverages sector also sees competition, with manufacturers incorporating apigenin in functional foods and beverages to cater to the rising demand for antioxidant-rich products. Moreover, the cosmetics industry is increasingly leveraging apigenin for its anti-aging and skin-soothing properties, intensifying competition in the beauty and personal care market. The global nature of the market encourages players to expand their footprint internationally, exploring new regional markets such as Asia-Pacific and Latin America, where consumer demand for natural health solutions is rapidly growing.

Recent Developments:

  • In May 2024, Tally Health launched its Restore Sleep and Longevity Formula, a blend of ingredients targeting improved sleep and overall longevity. The formula combines several botanicals and nutraceuticals aimed at promoting relaxation and reducing age-related health issues.
  • In April 2024, 4Life launched Transfer Factor AgePro, a new product combining apigenin with other powerful compounds aimed at enhancing immune support and promoting longevity. This product builds on 4Life's commitment to scientifically backed formulations and proprietary ingredients, including exclusive plant extracts, designed to boost health and wellness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL APIGENIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Monteloeder S.L.
  • Sigma-Aldrich Corporation
  • Aksuvital GIda Sanayi ve Ticaret A.S.
  • Bo International Pvt. Ltd.
  • Indo Phytochem Pharmaceuticals Pvt. Ltd.
  • Shaanxi QingLan Bio-Technology Co., Ltd.
  • Xi'an Incedit Bio-Tech Co., Ltd.
  • Xi'an Sost Biotech Co., Ltd.
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Xi'an Lyphar Biotech Co., Ltd.
  • Others

GLOBAL APIGENIN MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL APIGENIN MARKET, BY FORM - MARKET ANALYSIS, 2019 - 2032

  • Powder
  • Liquid

GLOBAL APIGENIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Dietary Supplements
  • Others

GLOBAL APIGENIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Apigenin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Apigenin Market Snippet by Source
    • 2.1.2. Apigenin Market Snippet by Form
    • 2.1.3. Apigenin Market Snippet by Application
    • 2.1.4. Apigenin Market Snippet by Country
    • 2.1.5. Apigenin Market Snippet by Region
  • 2.2. Competitive Insights

3. Apigenin Key Market Trends

  • 3.1. Apigenin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Apigenin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Apigenin Market Opportunities
  • 3.4. Apigenin Market Future Trends

4. Apigenin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Apigenin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Apigenin Market Landscape

  • 6.1. Apigenin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Apigenin Market - By Source

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 7.1.2. Natural
    • 7.1.3. Synthetic

8. Apigenin Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2024 & 2032 (%)
    • 8.1.2. Powder
    • 8.1.3. Liquid

9. Apigenin Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Pharmaceuticals
    • 9.1.3. Food & Beverages
    • 9.1.4. Cosmetics & Personal Care
    • 9.1.5. Dietary Supplements
    • 9.1.6. Others

10. Apigenin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Apigenin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Apigenin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Apigenin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Apigenin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Apigenin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Apigenin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Monteloeder S.L.
    • 11.2.2. Sigma-Aldrich Corporation
    • 11.2.3. Aksuvital GIda Sanayi ve Ticaret A.S.
    • 11.2.4. Bo International Pvt. Ltd.
    • 11.2.5. Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • 11.2.6. Shaanxi QingLan Bio-Technology Co., Ltd.
    • 11.2.7. Xi'an Incedit Bio-Tech Co., Ltd.
    • 11.2.8. Xi'an Sost Biotech Co., Ltd.
    • 11.2.9. Shaanxi Pioneer Biotech Co., Ltd.
    • 11.2.10. Xi'an Lyphar Biotech Co., Ltd.
    • 11.2.11. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us